MedStar Washington Hospital Center | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 3	2026-10-09		NCT07541079
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, male breast carcinoma, neoplasm, skin disorder	Recruiting	Phase 3	2026-09-15		NCT06492616
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)	Lung Injury, Respiration Disorders, acute lung injury, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder	Recruiting	Phase 2	2026-07-31		NCT06703073
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab	Lung Injury, Respiration Disorders, acute lung injury, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder	Recruiting	Phase 2	2026-07-31		NCT06701682
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart	Lung Injury, Respiration Disorders, acute lung injury, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder	Recruiting	Phase 2	2026-07-31		NCT06701669
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab	Lung Injury, Respiration Disorders, acute lung injury, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder	Recruiting	Phase 2	2026-07-31		NCT06701656